AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1570800 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate (HC) diet
Number of subjects: 21
Study 2416412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric tube insertion under direct laryngoscopy using Magill forceps
Number of subjects: 80
Study 2416412 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric tube insertion blindly during the surgical procedure
Number of subjects: 80
Study 30010228 — intervention group
Group type: EXPERIMENTAL
Intervention: Stricter parental rules
Number of subjects: 6300
Study 30010228 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher initial levels of sensation seeking
Number of subjects: 6300
Study 27100085 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump Squat (JS)
Number of subjects: 0
Study 27100085 — intervention group
Group type: COMPARATOR
Intervention: Olympic Push Press (OPP)
Number of subjects: 0
Study 24140033 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolutex (25 mg subcutaneously daily)
Number of subjects: 683
Study 24140033 — intervention group
Group type: COMPARATOR
Intervention: Crinone (90 mg 8% gel daily)
Number of subjects: 683
Study 22987458 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) at 153 kPa (1.5 ATA)
Number of subjects: 60
Study 22987458 — intervention group
Group type: COMPARATOR
Intervention: Sham air at 116 kPa (1.15 ATA)
Number of subjects: 60
Study 20594090 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong or Tai Chi interventions
Number of subjects: 77
Study 17414047 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (1,000 mg/d for 5 days) plus prednisolone (VP)
Number of subjects: 221
Study 17414047 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisolone (PP)
Number of subjects: 221
Study 17414047 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir plus prednisolone (VP) in cases of complete or severe palsy
Number of subjects: 221
Study 17414047 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisolone (PP) in cases of complete or severe palsy
Number of subjects: 221
Study 15184614 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar yoga class along with home practice
Number of subjects: 69
Study 15184614 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise class using a stationary bicycle along with home exercise
Number of subjects: 69
Study 15184614 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 69
Study 11434406 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum perforatum extract WS5572 (300 mg t.i.d.)
Number of subjects: 72
Study 11434406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 11434406 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum perforatum extract WS5572
Number of subjects: 72
Study 11434406 — intervention group
Group type: COMPARATOR
Intervention: Hypericum perforatum extract WS5572 and Placebo
Number of subjects: 72
Study 9164914 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 degrees head-up tilt for 5 minutes
Number of subjects: 26
Study 8435016 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms twice a day via a spacer
Number of subjects: 32
Study 8435016 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 1600 micrograms twice a day via a spacer and facemask
Number of subjects: 32
Study 8435016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 3300427 — intervention group
Group type: EXPERIMENTAL
Intervention: isoflurane
Number of subjects: 20
Study 3300427 — intervention group
Group type: COMPARATOR
Intervention: halothane
Number of subjects: 20
Study 29717032 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab (pooled all treatment doses)
Number of subjects: 0
Study 29717032 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 29717032 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite outcomes (including WOMAC pain and rescue medication use)
Number of subjects: 0
Study 27578313 — intervention group
Group type: EXPERIMENTAL
Intervention: MMA with preemptive analgesia
Number of subjects: 75
Study 27578313 — intervention group
Group type: COMPARATOR
Intervention: MMA without preemptive analgesia
Number of subjects: 75
Study 24876261 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue‐type plasminogen activator (tPA) followed by endovascular therapy
Number of subjects: 0
Study 24876261 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tissue‐type plasminogen activator (tPA) alone
Number of subjects: 0
Study 24876261 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy with routine use of general anesthesia
Number of subjects: 0
Study 24876261 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy without routine use of general anesthesia
Number of subjects: 0
Study 24876261 — intervention group
Group type: EXPERIMENTAL
Intervention: Embolectomy for IMS III subjects
Number of subjects: 0
Study 23865696 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin initiation 3 weeks after GnRHa administration (Group A)
Number of subjects: 85
Study 23865696 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin initiation 2 weeks after GnRHa administration (Group B)
Number of subjects: 85
Study 20528810 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-cessation nicotine patches and/or gum for 2 weeks prior to quit day
Number of subjects: 1100
Study 20528810 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 1100
Study 18837607 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help treatments
Number of subjects: 75
Study 16652426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular hyaluronic acid (HA) injections (20 mg/ml, 2 ml) administered once weekly for 3 weeks
Number of subjects: 106
Study 16652426 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) injections administered once weekly for 3 weeks
Number of subjects: 106
Study 12796754 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril
Number of subjects: 468
Study 12796754 — intervention group
Group type: COMPARATOR
Intervention: nisoldipine
Number of subjects: 468
Study 10750292 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT) after laparoscopic hysterectomy (LH) and/or bilateral salpingo‐oophorectomy (BSO)
Number of subjects: 286
Study 10750292 — intervention group
Group type: COMPARATOR
Intervention: No estrogen replacement therapy (control group)
Number of subjects: 286
Study 8943183 — intervention group
Group type: COMPARATOR
Intervention: Transabdominal approach (group I)
Number of subjects: 44
Study 8943183 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic transdiaphragmatic approach (group II)
Number of subjects: 44
Study 1424415 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose sotalol (320 mg)
Number of subjects: 10
Study 1424415 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated sotalol administration
Number of subjects: 10
Study 6147154 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 73 microgram kg‐1
Number of subjects: 60
Study 6147154 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium 99 microgram kg‐1
Number of subjects: 60
Study 6147154 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 60
Study 6147154 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 60
Study 6147154 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium and Pancuronium (1.6 ED95)
Number of subjects: 60
Study 30842540 — intervention group
Group type: EXPERIMENTAL
Intervention: UFP + O3
Number of subjects: 18
Study 30842540 — intervention group
Group type: COMPARATOR
Intervention: UFP
Number of subjects: 18
Study 30842540 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 18
Study 29921562 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based and mobile-based stress management interventions (iSMIs)
Number of subjects: 791
Study 29921562 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WLC)
Number of subjects: 791
Study 27176461 — intervention group
Group type: EXPERIMENTAL
Intervention: Bapineuzumab 0.5 mg/kg
Number of subjects: 1012
Study 27176461 — intervention group
Group type: EXPERIMENTAL
Intervention: Bapineuzumab 1.0 mg/kg
Number of subjects: 1012
Study 27176461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1012
Study 27176461 — intervention group
Group type: EXPERIMENTAL
Intervention: Bapineuzumab (both doses)
Number of subjects: 1012
Study 26040789 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (PHO)
Number of subjects: 60
Study 26040789 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle-stretching, aerobic, and facial exercises (EXT)
Number of subjects: 60
Study 26040789 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy plus exercise interventions (PHO + EXT)
Number of subjects: 60
Study 26040789 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 60
Study 26040789 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (PHO, EXT, PHO + EXT, Control)
Number of subjects: 60
Study 21824124 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser dermabrasion followed by hydrocortisone 17-butyrate cream and narrowband UVB treatment
Number of subjects: 18
Study 21824124 — intervention group
Group type: COMPARATOR
Intervention: Topical steroids and UVB alone
Number of subjects: 18
Study 21824124 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-treated side
Number of subjects: 18
Study 21824124 — intervention group
Group type: COMPARATOR
Intervention: UVB + steroids alone group
Number of subjects: 18
Study 20216113 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted dosing (MAP-BE)
Number of subjects: 40
Study 20216113 — intervention group
Group type: COMPARATOR
Intervention: Control (CONTR)
Number of subjects: 40
Study 18823199 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal integration of target and mask stimuli
Number of subjects: 0
Study 18823199 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial properties of the target and mask
Number of subjects: 0
Study 15695140 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous monteplase followed by PCI
Number of subjects: 0
Study 15695140 — intervention group
Group type: COMPARATOR
Intervention: Direct PCI
Number of subjects: 0
Study 11838852 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ice therapy, oral prednisone 30 mg PO tapered to 0 over 6 days, and colchicine 0.6 mg/day
Number of subjects: 19
Study 11838852 — intervention group
Group type: COMPARATOR
Intervention: Control group received the same regimen without ice therapy
Number of subjects: 19
Study 11838852 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ice therapy
Number of subjects: 19
Study 10354080 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) ointment 0.005% (g/g)
Number of subjects: 0
Study 10354080 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) ointment
Number of subjects: 0
Study 10354080 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 0
Study 7588895 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen plug implantation after coronary stenting
Number of subjects: 309
Study 7588895 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen plug implantation after PTCA
Number of subjects: 309
Study 7588895 — intervention group
Group type: COMPARATOR
Intervention: Conventional haemostasis after coronary stenting
Number of subjects: 309
Study 7588895 — intervention group
Group type: COMPARATOR
Intervention: Conventional haemostasis after PTCA
Number of subjects: 309
Study 2144866 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant vaccine, 10 micrograms in 1 ml intramuscularly
Number of subjects: 153
Study 2144866 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-derived vaccine, 2 micrograms in 0.1 ml intradermally
Number of subjects: 153
Study 2144866 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant vaccine, 1 microgram in 0.1 ml intradermally
Number of subjects: 153
Study 6137116 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cimetidine and pirenzepine
Number of subjects: 100
Study 6137116 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine or pirenzepine alone
Number of subjects: 100
Study 6137116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine and ranitidine as prophylaxis
Number of subjects: 100
Study 6137116 — intervention group
Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists and pirenzepine
Number of subjects: 100
Study 31249180 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Bass with lift the lip
Number of subjects: 40
Study 31249180 — intervention group
Group type: COMPARATOR
Intervention: Modified Bass without lift the lip
Number of subjects: 40
Study 31249180 — intervention group
Group type: COMPARATOR
Intervention: Horizontal technique with lift the lip
Number of subjects: 40
Study 31249180 — intervention group
Group type: COMPARATOR
Intervention: Horizontal technique without lift the lip
Number of subjects: 40
Study 28699090 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity interventions (specific details not provided)
Number of subjects: 172
Study 26545456 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (indoor treadmill)
Number of subjects: 40
Study 26545456 — intervention group
Group type: COMPARATOR
Intervention: Control group (indoor progressive-muscle relaxation/stretching)
Number of subjects: 40
Study 24513624 — intervention group
Group type: EXPERIMENTAL
Intervention: 15TT (15-second all-out sprint)
Number of subjects: 9
Study 24513624 — intervention group
Group type: COMPARATOR
Intervention: 90TT (90-second all-out sprint)
Number of subjects: 9
Study 24513624 — intervention group
Group type: COMPARATOR
Intervention: SPTT (self-paced time trial)
Number of subjects: 9
Study 24513624 — intervention group
Group type: EXPERIMENTAL
Intervention: 15TT
Number of subjects: 9
Study 24513624 — intervention group
Group type: EXPERIMENTAL
Intervention: 90TT
Number of subjects: 9
Study 22183192 — intervention group
Group type: EXPERIMENTAL
Intervention: PHAST PACES intervention (60 to 70 hours of instruction)
Number of subjects: 268
Study 22183192 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 268
Study 22183192 — intervention group
Group type: EXPERIMENTAL
Intervention: PHAST PACES intervention (1 year follow-up)
Number of subjects: 268
Study 21149774 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal analyses using change probability with total and pattern deviation
Number of subjects: 1570
Study 21149774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectional analyses using glaucoma hemifield test, corrected pattern standard deviation, and mean deviation
Number of subjects: 1570
Study 21149774 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern deviation analyses
Number of subjects: 1570
Study 21149774 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal and cross-sectional analyses
Number of subjects: 1570
Study 17702837 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of [(13)C]bicarbonate during exercise at 45% Vo(2peak)
Number of subjects: 19
Study 17702837 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of [(13)C]bicarbonate during exercise at 65% Vo(2peak)
Number of subjects: 19
Study 17702837 — intervention group
Group type: COMPARATOR
Intervention: Resting control trial
Number of subjects: 19
Study 17702837 — intervention group
Group type: EXPERIMENTAL
Intervention: Postexercise recovery at 45% Vo(2peak)
Number of subjects: 19
Study 17702837 — intervention group
Group type: EXPERIMENTAL
Intervention: Postexercise recovery at 65% Vo(2peak)
Number of subjects: 19
Study 16380390 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric group (HYPO) at sea level
Number of subjects: 26
Study 16380390 — intervention group
Group type: EXPERIMENTAL
Intervention: Deficient group (DEF) at 4,300 meters
Number of subjects: 26
Study 16380390 — intervention group
Group type: COMPARATOR
Intervention: Adequately fed group (ADQ) at 4,300 meters
Number of subjects: 26
Study 16380390 — intervention group
Group type: EXPERIMENTAL
Intervention: Both altitude groups (ADQ and DEF)
Number of subjects: 26
Study 15560830 — intervention group
Group type: EXPERIMENTAL
Intervention: Holding the drink in the mouth before swallowing
Number of subjects: 18
Study 15560830 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-sipping method
Number of subjects: 18
Study 15560830 — intervention group
Group type: EXPERIMENTAL
Intervention: Gulping
Number of subjects: 18
Study 15560830 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemetric method
Number of subjects: 18
Study 15560830 — intervention group
Group type: EXPERIMENTAL
Intervention: Microtouch method
Number of subjects: 18
Study 10797401 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training with heavy loads
Number of subjects: 13
Study 10797401 — intervention group
Group type: COMPARATOR
Intervention: Strength training with light loads
Number of subjects: 13
Study 10797401 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 13
Study 8970411 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (0.625 mg/day conjugated estrogens or 2 mg/day estradiol)
Number of subjects: 30
Study 8970411 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonusers)
Number of subjects: 30
Study 1455880 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy (cisplatin and bleomycin) and surgery
Number of subjects: 186
Study 1455880 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative irradiation (35 Gy) and surgery
Number of subjects: 186
Study 1455880 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy, radiotherapy, and surgery
Number of subjects: 186
Study 1455880 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 186
Study 6380905 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100-200 mg daily)
Number of subjects: 14
Study 6380905 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa (500-1000 mg daily)
Number of subjects: 14
Study 6380905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31331237 — intervention group
Group type: EXPERIMENTAL
Intervention: V#V sequences
Number of subjects: 0
Study 31331237 — intervention group
Group type: EXPERIMENTAL
Intervention: High first vowel in V#V sequences
Number of subjects: 0
Study 31331237 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-high first vowel in V#V sequences
Number of subjects: 0
Study 31331237 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphthongs
Number of subjects: 0
Study 28612330 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) applied after PRK for 5 seconds for each diopter of spherical equivalent myopic refractive error corrected.
Number of subjects: 48
Study 28699324 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery followed by 23-gauge pars plana vitrectomy (PPV)
Number of subjects: 62
Study 28699324 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV followed by cataract surgery
Number of subjects: 62
Study 28699324 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phacovitrectomy (PPV and cataract surgery simultaneously)
Number of subjects: 62
Study 28699324 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phacovitrectomy (COMBI group)
Number of subjects: 62
Study 28699324 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery and PPV (all groups)
Number of subjects: 62
Study 25432505 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundamental motor skill intervention
Number of subjects: 9
Study 25432505 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 9
Study 25432505 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (experimental and control)
Number of subjects: 9
Study 23270318 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on Yintang point
Number of subjects: 52
Study 23270318 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 52
Study 21571234 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 22
Study 21571234 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic breathing
Number of subjects: 22
Study 18563389 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-molar sodium-lactate (HL) solution, 10 ml kg BW(‐1) over 12 hours
Number of subjects: 208
Study 18563389 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate (RL) solution, 30 ml kg BW(‐1) over 12 hours
Number of subjects: 208
Study 16847538 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dependence only
Number of subjects: 119
Study 16847538 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid alcohol dependence and PTSD
Number of subjects: 119
Study 16847538 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD without alcohol dependence
Number of subjects: 119
Study 16847538 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study 12673136 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (1 yr resistance training, 60-75 min.d-1, 3 d.wk-1)
Number of subjects: 233
Study 12673136 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise group (no intervention)
Number of subjects: 233
Study 12673136 — intervention group
Group type: EXPERIMENTAL
Intervention: Total weight lifted in training sessions
Number of subjects: 233
Study 10907144 — intervention group
Group type: EXPERIMENTAL
Intervention: Older couples presenting for conjoint therapy
Number of subjects: 3
Study 10907144 — intervention group
Group type: COMPARATOR
Intervention: Younger couples presenting for conjoint therapy
Number of subjects: 3
Study 8799414 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional immunochemotherapy (Group B)
Number of subjects: 80
Study 8799414 — intervention group
Group type: COMPARATOR
Intervention: Standard operative procedure (Group A)
Number of subjects: 80
Study 1535447 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (0.5 mg nebulized)
Number of subjects: 16